CUSIP: 00974H104
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
54,965,124
-
Total 13F shares
-
16,061,952
-
Share change
-
+2,706,385
-
Total reported value
-
$118,696,041
-
Put/Call ratio
-
229%
-
Price per share
-
$7.39
-
Number of holders
-
72
-
Value change
-
+$17,919,115
-
Number of buys
-
50
-
Number of sells
-
21
Security key
00974H104
Report period
Q2 2023
Institutions
72
Top holders
10
Reporting periods
Holder history for CUSIP 00974H104
Recent filing periods:
Top shareholders of AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q2 2023
As of 30 Jun 2023,
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,061,952 shares.
The largest 10 holders included
Blue Water Life Science Advisors, LP, Polar Capital Holdings Plc, VANGUARD GROUP INC, BlackRock Inc., Board of Trustees of The Leland Stanford Junior University, Uniplan Investment Counsel, Inc., MILLENNIUM MANAGEMENT LLC, SVB WEALTH LLC, Granahan Investment Management, LLC, and Parkman Healthcare Partners LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2023 vs Q1 2023 Across Filers
| Investor |
Q1 2023 Shares |
Q2 2023 Shares |
Share Diff |
Share Chg % |
Q1 2023 Value $ |
Q2 2023 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.